NTX ventana reagents - order
Active Awarded Last action
- Contract number
- 36C25726N0321
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $230,039
Award facts
- Opportunity
-
- 6550-- Ventena Contract Request Special Notice · 36C25726Q0105 · Posted Feb 3, 2026
- Contract value 100% obligated
- $230,038.78 Current and potential, with all options
- Completion date 50% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation received a $230,038.78 firm fixed-price delivery order from Veterans Integrated Service Network 17 (VISN 17) for NTX Ventana Reagents, with performance in Castleton, Indiana and an ultimate completion date of April 20, 2027. This delivery order, awarded on April 21, 2026, was competitively awarded without set-aside designation and represents a child contract under a larger indefinite delivery vehicle or blanket purchase agreement. The award funds Roche's supply of Ventana histology staining reagents and consumables, which support automated immunohistochemistry and in-situ hybridization testing capabilities critical to pathology and diagnostic laboratory operations within the Veterans Health Administration.
VISN 17, part of the Department of Veterans Affairs, serves the veterans healthcare system across its assigned geographic region. Roche Diagnostics has established an extensive contracting relationship with the VA and Defense Health Agency, holding multiple indefinite delivery contracts and blanket purchase agreements valued in the millions of dollars for diagnostic equipment, analyzers, reagents, and laboratory automation systems across numerous VISNs and military medical facilities. The company's portfolio with federal healthcare agencies encompasses molecular diagnostics, clinical chemistry analysis, histology services, and point-of-care testing platforms, making it a primary supplier of advanced diagnostic capabilities to the military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract 36C25726N0321?
36C25726N0321 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on April 21, 2026.
How much is contract 36C25726N0321 worth?
The government has obligated $230,039 on 36C25726N0321.
Is contract 36C25726N0321 an order under another contract?
Yes. 36C25726N0321 is a delivery order under 36C25726D0065, an indefinite delivery contract.
Was contract 36C25726N0321 competed?
The extent of competition for 36C25726N0321 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award